Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BIIL-260 hydrochloride is a potent and long-acting orally active antagonist of leukotriene B4 (LTB4) receptor with anti-inflammatory activity. It has a high affinity to the LTB4 receptor on isolated human neutrophil cell membranes (Ki: 1.7 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 916.00 | |
50 mg | 6-8 weeks | $ 1,190.00 | |
100 mg | 6-8 weeks | $ 1,890.00 |
Description | BIIL-260 hydrochloride is a potent and long-acting orally active antagonist of leukotriene B4 (LTB4) receptor with anti-inflammatory activity. It has a high affinity to the LTB4 receptor on isolated human neutrophil cell membranes (Ki: 1.7 nM). |
Targets&IC50 | LTB4 receptor 1110:ki: 1.7 nM , MOP:ki: 1.8 nM , NOP:4.2 nM (ki) |
In vitro | BIIL-260 hydrochloride effectively inhibits LTB4-induced intracellular Ca2+ release in human neutrophils (IC50: 0.82 nM). |
Molecular Weight | 503.03 |
Formula | C30H31ClN2O3 |
CAS No. | 192581-24-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BIIL-260 hydrochloride 192581-24-1 Others BIIL 260 Hydrochloride BIIL260 hydrochloride BIIL-260 Hydrochloride BIIL260 Hydrochloride BIIL 260 hydrochloride inhibitor inhibit